loading

Denali Therapeutics Inc Azioni (DNLI) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
0.05%
137.37
137.43 134.96 145.58 123.19
Operating Income/Loss
0.05%
-137.37
-137.43 -134.96 -145.58 -123.19
Income/Loss From Continuing Operations Before Tax
1.22%
-128.45
-126.90 -124.12 -132.97 -107.19
Income/Loss From Continuing Operations After Tax
1.30%
-128.55
-126.90 -124.12 -132.97 -107.19
Net Income/Loss
1.30%
-128.55
-126.90 -124.12 -132.97 -107.19
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.45%
0.9469
172.42 171.45 171.22 169.46
Diluted Average Shares
99.45%
0.9469
172.42 171.45 171.22 169.46
Basic Earnings Per Share
1.35%
-0.73
-0.74 -0.72 -0.78 -0.63
Diluted Earnings Per Share
1.35%
-0.73
-0.74 -0.72 -0.78 -0.63
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):